IRESS LIMITED — Director's Dealing 2011

May 19, 2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity IRESS Market Technology Limited ABN 47 060 313 359

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Andrew Walsh
Date of last notice	25 May 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change		17 May 2011 (This form is being reissued as old format Appendix 3Y was used in earlier announcement)
No. of securities held prior to change		Ordinary Shares Direct:_70,950 Unvested Share Grants: _Direct: Performance Rights ‘07: Nil Performance Rights ‘08: 56,000 Performance Rights ‘09: 100,000 Deferred Shares’08: Nil Deferred Shares’09: 25,000 Performance Rights ‘10: 125,000 Deferred Shares’10: 29,000

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class		Ordinary
Number acquired		Ordinary Shares Direct:_151,950 Unvested Share Grants: _Direct: Performance Rights issued May 2011: 4 year term measurement commencing May 2011: 150,000 3 year term measurement commencing May 2012: 150,000 Deferred Shares’11: 30,000
Number disposed		Ordinary Shares _Direct:_Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Ordinary Shares: As per the Performance Rights plan, the exercise price is$1 per series per participant. There is no exercise price for Deferred Shares. Accordingly, the total consideration (in aggregate) was$1
No. of securities held after change		Ordinary Shares Direct:_151,950 Unvested Share Grants: _Direct: Performance Rights ‘08: Nil Performance Rights ‘09: 100,000 Deferred Shares’09: Nil Performance Rights ‘10: 125,000 Deferred Shares’10: 29,000 Performance Rights issued May 2011: 4 year term measurement commencing May 2011: 150,000 3 year term measurement commencing May 2012: 150,000 Deferred Shares’11: 30,000
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Vesting of share grants made in prior periods & Share grant offer made in May 2011.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	All transactions subject to this announcement (vesting of prior year share grants and issue of new share grants) arose from transactions previously approved by both shareholders and board.
If so, was prior written clearance provided to allow the trade to proceed during this period?	Exercise of vested performance rights was advised to Chairman. Chairman advised quantum of 2011 sharegrants.
If prior written clearance was provided, on what date was this provided?	16 May 2011

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3